Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug 23;17(10):92.
doi: 10.1007/s11892-017-0918-8.

Weight Management in Patients with Type 1 Diabetes and Obesity

Affiliations
Review

Weight Management in Patients with Type 1 Diabetes and Obesity

Adham Mottalib et al. Curr Diab Rep. .

Abstract

Purpose of review: Patients with type 1 diabetes (T1D) are typically viewed as lean individuals. However, recent reports showed that their obesity rate surpassed that of the general population. Patients with T1D who show clinical signs of type 2 diabetes such as obesity and insulin resistance are considered to have "double diabetes." This review explains the mechanisms of weight gain in patients with T1D and how to manage it.

Recent findings: Weight management in T1D can be successfully achieved in real-world clinical practice. Nutrition therapy includes reducing energy intake and providing a structured nutrition plan that is lower in carbohydrates and glycemic index and higher in fiber and lean protein. The exercise plan should include combination stretching as well as aerobic and resistance exercises to maintain muscle mass. Dynamic adjustment of insulin doses is necessary during weight management. Addition of anti-obesity medications may be considered. If medical weight reduction is not achieved, bariatric surgery may also be considered.

Keywords: Anti-obesity medications; Bariatric surgery; Nutrition therapy; Obesity; Type 1 diabetes; Weight management.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Adham Mottalib, Megan Kasetty, Jessica Y. Mar, Taha Elseaidy, and Sahar Ashrafzadeh declare that they have no conflict of interest.

Osama Hamdy reports grants from National Dairy Council, Novo Nordisk, Abbott Nutrition, Intarcia, Inc., and Metagenics, Inc., personal fees from AstraZeneca and Merck, and is a shareholder for Healthimation, LLC.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

    1. Kjær IGH, Kolle E, Hansen BH, Anderssen SA, Torstveit MK. Obesity prevalence in Norwegian adults assessed by body mass index, waist circumference and fat mass percentage. Clinical Obesity. 2015;5(4):211–218. - PubMed
    1. •• Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315(21):2284-91. doi:10.1001/jama.2016.6458. This report utilizes data from the National Health and Nutrition Examination Survey (NHANES) to describe the alarming changes in obesity trends in the US. - PMC - PubMed
    1. Ghosh A, Charlton KE, Batterham MJ. Socioeconomic disadvantage and its implications for population health planning of obesity and overweight, using cross-sectional data from general practices from a regional catchment in Australia. BMJ Open. 2016;6(5):e010405. - PMC - PubMed
    1. Szadkowska A, Madej A, Ziolkowska K, Szymanska M, Jeziorny K, Mianowska B, et al. Gender and age-dependent effect of type 1 diabetes on obesity and altered body composition in young adults. Annals of Agricultural and Environmental Medicine: AAEM. 2015;22(1):124–128. - PubMed
    1. Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, et al. Temporal patterns in overweight and obesity in type 1 diabetes. Diabet Med. 2010;27(4):398–404. - PMC - PubMed